JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 54(2020) N 2 p. 269-273; DOI 10.1134/S0026893320020053 Full Text

Yu.M. Khodarovich1*, D.D. Rakhmaninova1, A.M. Barishnikova1, S.M. Deyev1

Doxycycline Sensitive Two-Promoter Integrator Based on the TET-ON 3G Transactivator

1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, 117997 Russia

*khodarovich@mail.ru
Received - 2019-10-10; Revised - 2019-10-10; Accepted - 2019-11-05

A synthetic genetic chain was created-a two-promoter integrator, the activity of the output signal of which is high only with the high activity of two promoters at the input of the chain. The integrator is shown to work by the example of cancer-specific promoters of the human survivin and telomerase genes that can be used for specific transcription of target genes in tumor cells. To create the integrator, we used the well-known TET-ON 3G transactivator, regulated by doxycycline.

synthetic biology, gene chains, integrator, transactivator, gene therapy, oncology



JMB-FOOTER RAS-JOURNALS